** Shares of pharma and biotech co Wockhardt WCKH.NS rise
as much as 12% to 943 rupees, highest since August 5, 2016
** Stock on track for an eleventh consecutive session of
gain, if trends hold
** On Monday, WCKH's shares rose an exchange-allowed maximum
of 20% after its antibiotic drug Zaynich successfully treated a
cancer patient in the U.S.
** Share price above 50-day, 100-day and 200-day exponential
moving averages since June 19
** Trading vol 2.9x 30-day daily avg
** Stock rose 17.2% in June quarter, its third straight
quarterly rise
** Stock last up 6.7%, pushing YTD gains to 111.5%
(Reporting by Ashish Chandra in Bengaluru)
((ashish.chandra@thomsonreuters.com (+91 7982114624))